Journal of the Neurological Sciences
Volume 290, Issue 1 , Pages 96-101 , 15 March 2010

The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: A longitudinal SPECT study

  • Haruo Hanyu

      Affiliations

    • Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Department of Geriatric Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku Shinjuku-ku, Tokyo 160-0023, Japan. Tel.: +81 3 3342 6111; fax: +81 3 3342 2305.
    • ,
  • Tomohiko Sato

      Affiliations

    • Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
    • ,
  • Kentaro Hirao

      Affiliations

    • Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
    • ,
  • Hidekazu Kanetaka

      Affiliations

    • Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
    • ,
  • Toshihiko Iwamoto

      Affiliations

    • Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan
    • ,
  • Kiyoshi Koizumi

      Affiliations

    • Department of Radiology, Tokyo Medical University, Tokyo, Japan

Received 8 April 2009 ,Revised 29 October 2009 ,Accepted 30 October 2009.

References 

  1. Lucca U, Comelli M, Tettamanti M, Tiraboschi P, Spagnoli A. Rates of progression and prognostic factors in Alzheimer's disease: a prospective study. J Am Geriatr Soc. 1993;41:45–49
  2. Stern Y, Albert S, Tang M-X, Tsai W-Y. Rate of memory decline in AD is related to education and occupation. Neurology. 1999;53:1942–1947
  3. Andel R, Vigen C, Mack WJ, Clark LJ, Gatz M. The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc. 2006;12:147–152
  4. Boksay I, Boksay E, Reisberg B, Torossaian C, Krishnamurthy M. Alzheimer's disease and medical disease conditions: a prospective cohort study. J Am Geriatr Soc. 2005;53:2235–2236
  5. Miller TP, Tinklenberg JR, Brooks JO, Yesavage JA. Cognitive decline in patients with Alzheimer's disease: differences in patients with and without extrapyramidal signs. Alzheimer Dis Assoc Disord. 1991;5:251–256
  6. Rosen J, Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiatry. 1991;29:224–232
  7. Wolfe N, Reed BR, Eberling JL, Jagust WJ. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch Neurol. 1995;52:257–262
  8. Brown DRP, Hunter R, Wyper DJ, Patterson J, Kelly RC, Montaldi D, et al. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. J Psychiat Res. 1996;30:109–126
  9. Jagust WJ, Haan MN, Reed BR, Eberling JL. Brain perfusion imaging predicts survival in Alzheimer's disease. Neurology. 1998;51:1009–1013
  10. Nagahama Y, Nabatame H, Okina T, Yamauchi H, Narita M, Fujimoto N, et al. Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Neurol. 2003;50:1–9
  11. Nishimura T, Hashikawa K, Fukuyama H, Kubota T, Kitamura S, Matsuda H, et al. Decreased cerebral blood flow and prognosis of Alzheimer's disease: a multicenter HMPAO-SPECT study. Ann Nucl Med. 2007;21:15–23
  12. Mann UM, Mohr E, Gearing M, Chase TN. Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatry. 1992;55:956–959
  13. Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, et al. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geritar Cogn Disord. 1999;10:494–504
  14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health anf Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–944
  15. Highes CP, Berg L, Danzieger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572
  16. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  17. Anderson TM, Sachdev PS, Brodaty H, Trollor JN, Andrews G. Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians. Am J Geriatr Psychiatry. 2007;15:467–476
  18. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238–1248
  19. Talairach J, Tournoux P. Co-planar Stereotactic Atlas of the Human Brain. New York: Thieme; 1998;
  20. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528–1537
  21. Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, et al. Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med. 2003;17:289–295
  22. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practical parameter: diagnosis of dementia (an evidence-based review), report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143–1153
  23. Tolnay M, Clavaguera F. Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. Neuropathology. 2004;24:269–283
  24. Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, et al. Staging of argyrophilic grains: an age-associated tauopathy. J Neuropath Exp Neurol. 2004;63:911–918
  25. Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol. 2007;113:107–117
  26. Yamada M. Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology. 2003;23:311–317
  27. Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, et al. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease. Arch Neurol. 1999;56:857–862
  28. Haxby JV, Raffaele K, Gillette J, Schapiro MB, Rapoport SI. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1992;14:575–592
  29. Han L, Cole M, Bellevance F, McCusker J, Primeau F. Tracking cognitive decline in Alzheimer's disease using the mini-Mental State Examination: a meta-analysis. Int Psychogeriatr. 2000;12:231–247
  30. Karp A, Kareholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L. Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease. Am J Epidemiol. 2004;159:175–183
  31. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3:342–353
  32. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med. 2001;15:85–92
  33. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 1996;47:444–448
  34. Murphy GM, Taylor J, Kraemer HC, Yesavage J, Tinklenberg JR. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Am J Psychiatry. 1997;154:603–608
  35. Kleiman T, Zdanys K, Black B, Rightmen T, Grey M, Garman K, et al. Apolipoprotein E epsilon 4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord. 2006;22:73–82
  36. Ishii K, Willoch F, Minoshima S, Drzega A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med. 2001;42:548–557

PII: S0022-510X(09)00940-X

doi: 10.1016/j.jns.2009.10.022

Journal of the Neurological Sciences
Volume 290, Issue 1 , Pages 96-101 , 15 March 2010

Article Tools

* Image Usage & Resolution